98
Views
4
CrossRef citations to date
0
Altmetric
Case Reports

Nasolacrimal system obstruction, ptosis and esotropia due to chemotherapy in acute lymphoblastic leukemia

, , , &
Pages 330-332 | Received 09 Oct 2012, Accepted 18 Dec 2012, Published online: 06 Mar 2013

References

  • McNab AA. Lacrimal canalicular obstruction associated with topical ocular medication. Aust N Z J Ophthalmol 1998;26:219–23
  • Chauvenet AR, Shashi V, Pediatric Oncology Group Study, et al. Vincristine-induced neuropathy as the initial presentation of charcot-marie-tooth disease in acute lymphoblastic leukemia: a Pediatric Oncology Group study. J Pediatr Hematol Oncol 2003;25:316–20
  • McCartney E, Valluri S, Rushing D, Burgett R. Upper and lower system nasolacrimal duct stenosis secondary to paclitaxel. Ophthal Plast Reconstr Surg 2007;23:170–1
  • Esmaeli B. Management of excessive tearing as a side effect of docetaxel. Clin Breast Cancer 2005;5:455–7
  • Brink HM, Beex LV. Punctal and canalicular stenosis associated with systemic fluorouracil therapy. Report of five cases and review of the literature. Doc Ophthalmol 1995;90:1–6
  • Wong EY, Harding A, Kowal L. Oxybutynin-associated esotropia. JAAPOS. 2007;11:624–5
  • Esmaeli B, Amin S, Valero V, et al. Prospective study of incidence and severity of epiphora and canalicular stenosis in patients with metastatic breast cancer receiving docetaxel. J Clin Oncol 2006;24:3619–22
  • Carruthers J, Carruthers A. Complications of botulinum toxin type A. Facial Plast Surg Clin North Am 2007;15:51–4
  • Gursel O, Sari E, Altun D, et al. Vincristine-induced unilateral ptosis in a child. Pediatr Neurol 2009;41:461–3
  • Santos FX, Parolin A, Lindoso EM, et al. Intracranial hypertension with ocular manifestation during the use of tetracycline: case report. Arq Bras Oftalmol 2005;68:701–3
  • Straus DJ, Mausolf FA, Ellerby RA, McCracken JD. Cicatricial ectropion secondary to 5-fluorouracil therapy. Med Pediatr Oncol 1977;3:15–19
  • Caravella L, Burns J, Zangmeister M. Punctal-canalicular stenosis related to systemic fluorouracil therapy. Arch Ophthalmol 1981;99:284–6
  • Doroshow JH, Locker GY, Gasterland DE, et al. Ocular irritation from high-dose methotrexate therapy: pharmacokinetics of drug in the tear film. Cancer 1981;48:2158–62
  • Fraunfelder FT, Meyer SM. Ocular toxicity of antineoplastic agents. Ophthalmology 1983;90:1–3
  • Stevens A, Spooner D. Lacrimal duct stenosis and other ocular toxicity associated with adjuvant cyclophosphamide, methotrexate and 5-fluorouracil combination chemotherapy for early stage breast cancer. Clin Oncol 2001;13:438–40

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.